1790EGP
- Active ingredient
- fluticasone+umeclidinium+vilanterol
- Strength
- 100/62.5/25 mcg
- Form
- spray
- Manufacturer
- glaxo smithkline
- Route
- spray
Uses
Maintenance treatment of COPD and maintenance treatment of asthma in adults. Not intended for relief of acute bronchospasm.
Do not use if
Acute severe asthma or COPD episodes and severe hypersensitivity to milk proteins or any component.
Side effects
May cause oral candidiasis, pneumonia in COPD patients, headache, cough, and upper respiratory infections.
Warnings
Do not use for acute symptoms and avoid combining with other LABA-containing therapies.
How it works
Combines an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta2 agonist.
Storage
Store in a dry place at room temperature and keep in the sealed package until use.
